The Missing Link Between Diagnosis and Support

Imagine applying the following logic in oncology:

• We can identify the disease.

• We can monitor the disease.

• We can describe the disease.

• Therefore, we have adequately planned for the disease.

The statement sounds absurd because every healthcare professional understands what is missing.

Diagnosis is only the beginning.

Once cancer is identified, attention immediately turns toward treatment planning, care coordination, risk management, functional impact, patient support, follow-up, and long-term outcomes.

No one confuses diagnosis with a plan.

Yet Alzheimer's disease occupies a curious space in modern healthcare.

We continue to improve our ability to identify Alzheimer's disease. Biomarkers are advancing. Blood-based testing is expanding. Earlier detection is becoming possible. Disease-modifying therapies are emerging; these advances matter.

But as diagnostic precision improves, a different question becomes increasingly difficult to ignore: What is the operational response to the diagnosis of Alzheimer's disease?

For a disease that may unfold over ten to twenty years – progressively affecting communication, judgment, executive functioning, safety awareness, daily living skills, behavior, caregiver burden, and independence – that answer remains surprisingly absent from routine clinical practice.

Yet Alzheimer's care continues to rely heavily on diagnostic classification and broad staging terminology.

• Mild

• Moderate

• Severe

Or:

• Early-stage

• Middle-stage

• Late-stage

These classifications help describe progression. They do not direct support.

Knowing that an individual has moderate Alzheimer's disease tells us remarkably little about the decisions that will shape their safety, independence, and quality of life tomorrow morning:

• Are they at risk for wandering?

• Can they safely manage medications?

• Should they still be driving?

• Can they prepare meals without supervision?

• Does communication need to be modified?

• Should caregiver supports already be in place?

• Is a preventable crisis already developing?

A stage designation may describe the disease; it does not tell us what to do about it.

Diagnosis: identifies disease. Stage: describes progression. Assessment: identifies support needs. Planning: directs individualized action.

And that distinction matters because Alzheimer's is diagnosed neurologically but experienced functionally.

• It is experienced through Silver Alerts when someone leaves home and cannot find their way back.

• It is experienced through medication overdoses when an individual no longer remembers having already taken their medication and takes it again.

• It is experienced through kitchen fires started by someone who forgot there was nothing in the pan.

• It is experienced through financial exploitation, preventable falls, wandering events, emergency room visits, caregiver exhaustion, and the progressive loss of independence that follows.

• In some cases, it is experienced through tragedy. A person who leaves home on a winter night. A person who attempts to return to a place that exists only in memory. A family receiving a phone call that arrives too late.

These are not isolated stories.

They are the functional consequences of a progressive neurological disease.

And unlike the underlying pathology, many of these risks are observable long before they become crises.

We routinely anticipate and proactively manage foreseeable risks in other progressive health conditions.

Why have we accepted a lower level of operational planning for Alzheimer's disease?

Yet while diagnostic science continues to advance at a remarkable pace, the systematic translation of diagnosis into individualized support planning remains conspicuously underdeveloped.

As both a Licensed Behavior Specialist and Certified Dementia Practitioner, I find myself returning to a principle that many disciplines accepted long ago:

• Diagnosis: identifies a condition.

• Assessment: identifies functional impact.

• Planning: directs intervention.

• Support: builds around function, not diagnosis alone.

Two individuals with the same diagnosis may require entirely different supports, interventions, communication strategies, environmental adaptations, and risk-management plans.

The diagnosis may be identical; the care plan should not be.

Perhaps the next evolution in Alzheimer's care is not simply earlier detection; perhaps it is developing a systematic process for operationalizing individualized support.

Because identifying disease is a clinical achievement.

Operationalizing support is a clinical responsibility.

And for a disease with such profound functional consequences, that responsibility deserves far greater attention than it currently receives.

Next in this series:

What Should Happen After the Diagnosis?